HEALTHCARE · BIOTECHNOLOGY

Caris Life Sciences Inc. Common Stock (CAI) Stock Price, Analysis & Trade Signals

$14.51-2.26 (-13.45%)

Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and machine learning algorithms. The company's molecular profiling services portfolio includes MI Profile, a tissue-based molecular profiling solution; and Caris Assure, a blood-based molecular profiling solution for cancer treatment. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research ser…

Market Cap
$5.20B
CEO
David Dean Halbert
Employees
1,769
IPO Date
2025-06-18
Website
www.carislifesciences.com

Tabs · Summary · AI Insight · Feed · News · Financials · Transcript · SEC Filings · Insider · Politics